CRKL and T-cell leukemia: The T-cell leukemia cell line, Jurkat, revealed parallel findings in CrkL mobility with mimicked antigenic stimulation (TCR stimulation) by anti-CD3 monoclonal antibodies (α-CD3), in combination with recombinant human B7.1 (rhB7.1).